CAMBRIDGE POLYMER GROUP INC — Department of Health and Human Services SBIR Phase I: NEI

Description

Project Summary Retinal disorders are a common cause of debilitating vision loss For many of these conditions including retinal detachments and macular holes the only treatment is surgery The first step of all such surgeries is vitrectomy the process of removing the vitreous gel through tiny ports in the front of the eye Each year million vitrectomies are performed globally with performed in the US alone and in the majority of these cases a retinal tamponade is required to be left in the eye to maintain pressure on the retina and aid healing The global retinal tamponade market was recently valued at USD $ million in and is predicted to reach USD $ million by The current state of the art uses either an expansile gas or a silicone oil to exert pressure on the retina during healing tamponade However neither method is ideal and therefore to address these deficiencies this proposal develops a novel hydrogel that uses two common synthetic biomedical polymers namely a modified poly vinyl alcohol and poly ethylene glycol in a form that creates a unique hydrogel system that is very low viscosity in liquid form but then gels through crosslink formation in the eye This formulation allows for injection through small surgical ports followed by in vivo expansion resulting in degree retinal tamponade This unique formulation will eliminate the need for post operative patient positioning Additionally this hydrogel degrades over the period of weeks providing a temporary tamponade force before degrading to small molecules that are readily cleared from the eye thus removing the need for subsequent surgeries to remove the tamponade agent The resulting device will be more patient friendly with almost no refractive issues and the ability for the patient to be fully mobile Patient compliance will therefore be improved In addition it will also act as a tamponade only for the surgically relevant period of time before clearing naturally through a degradation process reducing costs and improving outcomes Project Narrative Retinal disorders are a common cause of debilitating vision loss and the surgical solutions to repairing them are generally problematic for outcomes and patient compliance We propose a new hydrogel based solution that will be optically similar to the native vitreous while exerting a controlled force tamponade on the healing retina and then degrade naturally after the end of its useful life This new device will therefore result in improved patient compliance and outcomes and reduced surgical visits